## CRDO: Credo Technology Group Holding Ltd - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.10 indicates fundamental undervaluation. Quality metrics strong (ROE 23%, ROA 12%). Consistent execution (4/4 quarters beat estimates). Caution: declining volume (40% of avg).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($123.94)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Credo Technology Group (NASDAQ:CRDO) Insider Sells $1,500,000.00 in Stock**
- Source: MarketBeat | 20251229T200957 | Somewhat-Bullish | Relevance: 100%
- Credo Technology Group (NASDAQ:CRDO) director James Laufman sold 10,000 shares of the company's stock for $1.5 million on December 24th, reducing his stake by 4.45%. This sale follows a strong earnings quarter where the company reported $0.67 EPS against an expected $0.49 and revenue of $268.0 million, significantly exceeding consensus estimates. Analysts currently rate CRDO with an average "Buy," with an average price target of $206.85.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 5, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Roth Capital | $250 | $170 | +47% |
| 2025-12-02 | Mizuho | $225 | $165 | +36% |
| 2025-12-02 | B of A Securiti | $240 | $165 | +45% |
| 2025-12-02 | Barclays | $220 | $165 | +33% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Roth Capital | main | Buy |
| 2025-12-02 | Mizuho | main | Outperform |
| 2025-12-02 | B of A Securiti | main | Buy |
| 2025-12-02 | Barclays | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.00M) |
| Sells | 32 ($20.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Blackrock Inc.: 9.7% (+18.1%)
- Vanguard Group Inc: 9.2% (+0.9%)
- JPMORGAN CHASE & CO: 8.5% (+136.6%)
- Price (T.Rowe) Assoc: 3.0% (+563.8%)
- Point72 Asset Manage: 2.6% (+15.3%)

### Key Risks

1. High beta (2.63) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Heavy insider selling: $21M sold (32 transactions in 90 days).
3. Near-term weakness: 7.6% below SMA50 despite long-term uptrend.

### Catalysts

- Analyst target momentum: 5 raises (avg +36%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.10 indicates undervaluation relative to growth. Quality metrics strong (ROE 23%, ROA 12%, margin 27%). Balance sheet: strong liquidity (8.9x), low leverage (D/E 0.13). Revenue growth strong at 40% YoY. Analyst sentiment positive (5 raises, avg +36%). Insider selling cluster ($20.7M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.2B |
| Beta | 2.63 |
| 52W Range | $29.09 - $213.80 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.10 |
| Forward P/E | 38.9 |
| Current P/E | 52.1 |
| YoY Growth | 34.0% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -8.8% to -7.4% (+1.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 11.4pp (needs >4.0% for momentum thesis). AM_20 at -7.3% indicates price below own 20MA trend. Underperforming sector by 7.6pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.34x) but short-term weakness (below SMA20). MACD histogram bearish (-0.84), momentum weakening. RSI neutral at 44. Volume at 40% of 20MA suggests lack of conviction. OFD pattern: +DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -7.41% (CS: 5) | Weak |
| RSI_14 | 44.4 | Neutral |
| MACD Histogram | -0.84 | Bearish |
| vs SMA20 | 0.927x | Below |
| vs SMA50 | 0.924x | Below |
| vs SMA200 | 1.339x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $144.92
- **Stop Loss:** $123.94 (14.5% risk)
- **Target:** $186.88 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 52
- **Position Value:** $7,535.84
- **Portfolio %:** 7.54%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-03-03 (Est: $0.79)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.50 | $0.67 | +35.3% |
| 2025Q3 | $0.36 | $0.52 | +44.2% |
| 2025Q2 | $0.27 | $0.35 | +27.9% |
| 2025Q1 | $0.18 | $0.25 | +36.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*